SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-279564
Filing Date
2021-09-22
Accepted
2021-09-22 17:20:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d234004d424b5.htm 424B5 509652
2 GRAPHIC g234004g0330155742599.jpg GRAPHIC 2692
3 GRAPHIC g234004g0330155742770.jpg GRAPHIC 3138
  Complete submission text file 0001193125-21-279564.txt   519324
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237413 | Film No.: 211270319
SIC: 8071 Services-Medical Laboratories